Both in Biotechnology
LENZ Therapeutics vs enGene Therapeutics
Over the past year LENZ returned −89.1% and ENGN returned −79.0%; their daily moves had a correlation of 0.08.
LENZ −89.1% ENGN −79.0%Growth of $1, one year, split-adjusted
| Metric | LENZ | ENGN |
|---|---|---|
| Price | $3.05 | $1.45 |
| Market cap | $95.8M | $97.2M |
| Today | 0.00% | −5.23% |
| 1 month | −14.8% | −25.3% |
| 6 months | −67.1% | −80.9% |
| Year to date | −80.9% | −83.9% |
| 1 year | −90.0% | −79.2% |
| Revenue growth (YoY) | +9.7% | — |
| Gross margin | 94.9% | — |
| Net margin | −581.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.5× | — |
| Net cash | $220.0M | $241.0M |
| Dividend yield | — | — |
| Volatility (60d) | 69.9% | 52.8% |
| Short % of float | 46.7% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).